Pharmacological Therapies for Peripheral Vascular Disease
Patients with peripheral vascular disease (PVD) are at increased risk of death when compared with age-matched healthy controls. They are also, whether symptomatic or not, six times more likely to die within ten years when compared to patients without the disease. This excess mortality exists even if coronary artery disease is not clinically present, and makes the treatment of PVD a highly important and pressing topic. In this fully up-to-date text, Dr. Mukherjee and his excellent team of twenty-one contributors present the reader with all of the currently available clinical information for treating PVD patients effectively.
Table of Contents
Arterial Diseases 1. Lifestyle changes and risk factor modification 2. Pentoxifylline and Cilostazol 3. Antiplatelet therapy 4. Lipid Lowering therapy 5. ACE/ARB in peripheral arterial diseases 6. Beta blockers in peripheral arterial diseases 7. Fibrinolytic therapy in peripheral arterial diseases 8. Antithrombotic therapies 9. Miscellaneous agents [Naftidrofuryl, Prostaglandins, L-arginine] 10. Pharmacotherapy for global cardiovascular risk reduction Venous Diseases 11. Deep venous thrombosis / Pulmonary Embolism pharmacotherapy 12. Compression stockings and sclerosing agents